Sarah J. Schrieber

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research

Immunology and MicrobiologyMedicineMathematicsPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C”.

Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

UNC Libraries(2020)10.17615/nfrz-fv42

N/A

0DataRank · unranked

0 citations

Steven H. Belle, Tedi A. Soule, Abdus S. Wahed, SyNCH Trial Group, Josh Berman +10 more

Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects

Clinical and Translational Science(2025)10.1111/cts.70412

N/A

0DataRank · unranked

0 citations

Deepti Pranay Samarth, Kristina E. Howard, Yan Guo, Esraa G. Mohamed, Erica Decker +10 more